Dose-ranging study of CP-99,219 (trovafloxacin) for treatment of uncomplicated gonorrhea.
Thirty-nine patients with uncomplicated gonorrhea were randomized to receive single, oral 50-, 100-, or 200-mg doses of trovafloxacin (CP-99,219), a new quinolone antibiotic. All 31 evaluable patients were cured of infection. Trovafloxacin was well tolerated. The trovafloxacin MICs at which 50 and 9...
Na minha lista:
| Udgivet i: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society for Microbiology (ASM)
1996
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163403/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8807070/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.40.7.1720 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
